RECRUITING

Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Although most people recover from acute pain (such as pain caused by injury, surgery, repetitive motion, or unknown causes), many people do not fully recover and will experience chronic pain. Untreated posttraumatic stress disorder (PTSD) appears to be a key risk factor for the transition from acute pain to chronic pain. However, few published studies have addressed the issue of preventing the transition from acute to chronic pain via PTSD reduction. This project will aim to test whether trauma-related PTSD symptoms can be reduced using either Stellate Ganglion Block (SGB) treatment or Cognitive Processing Therapy (CPT), and whether reducing PTSD symptoms can prevent the transition from non-injury based acute pain to chronic pain.

Official Title

Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

Quick Facts

Study Start:2023-09-01
Study Completion:2027-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05700279

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 to 70 years
  2. 2. Ability to read and write English sufficiently to understand and complete study questionnaires and participate in interviews
  3. 3. Presenting to the Rush ED with acute pain without debilitating trauma
  4. 4. A primary acute pain site
  5. 5. Self-reported symptoms consistent with a diagnosis of PTSD
  6. 6. People with well-controlled diabetes or HIV/AIDS with chronic neuropathic pain will be included if their acute pain complaint at ED presentation is not due to neuropathic pain
  7. 7. Individuals with a history of psychotic or bipolar disorder that is currently well managed, have been treated for the condition for at least 3 months, are able to coherently answer interview questions, and are judged by study staff to be capable of participating in study
  8. 8. Current chronic illness that involves constant or frequent pain if their acute pain complaint at ED presentation is not due to the chronic illness. (case-by-case basis)
  9. 9. Current chronic pain from various sources if their acute pain complaint at ED presentation is not related to their current chronic pain. (case-by-case basis)
  1. 1. Pain intensity great enough to impair concentration or capacity to understand instructions or the nature of being invited into a study as assessed by a member of the medical staff
  2. 2. Any injury or illness that precludes their ability to understand or follow instructions as assessed by a member of the medical staff
  3. 3. Self-reported history of chronic pain on presentation to the ED or documented in the electronic medical record (case-by-case basis)
  4. 4. Pain from traumatic event that is the source of their PTSD
  5. 5. Neurological disorder
  6. 6. Blood pressure greater than 160/100 mmHg
  7. 7. Taking anticoagulants or antiplatelet drugs other than aspirin
  8. 8. Pregnancy
  9. 9. Current alcohol or substance dependence
  10. 10. Anything that precludes interventions from being successful.
  11. 11. We will exclude people who are being treated for chronic or significant diseases such as rheumatoid disease, current influenza that may manifest temporary flu- related pain, and heart disease.

Contacts and Locations

Study Contact

John W Burns, PhD
CONTACT
312-942-0379
john_burns@rush.edu

Principal Investigator

John W Burns, PhD
PRINCIPAL_INVESTIGATOR
Rush University Medical Center

Study Locations (Sites)

Rush University Medical Center
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: Rush University Medical Center

  • John W Burns, PhD, PRINCIPAL_INVESTIGATOR, Rush University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-01
Study Completion Date2027-02-01

Study Record Updates

Study Start Date2023-09-01
Study Completion Date2027-02-01

Terms related to this study

Keywords Provided by Researchers

  • PTSD
  • Chronic Pain
  • Acute Pain

Additional Relevant MeSH Terms

  • PTSD
  • Chronic Pain